ストックスクリーナーアプリを入手
6.83
0.15%
-0.010
アフターアワーズ：
6.84
0.010
+0.15%
前日終値:
$6.84
開ける：
$6.65
24時間の取引高:
1.15M
Relative Volume:
0.66
時価総額：
$529.43M
収益：
$14.79M
当期純損益:
$-102.44M
株価収益率:
-2.2467
EPS:
-3.04
ネットキャッシュフロー:
$-91.73M
1週間 パフォーマンス:
-2.43%
1か月 パフォーマンス:
+48.48%
6か月 パフォーマンス:
+114.78%
1年 パフォーマンス:
-20.95%
1日の値動き範囲:
$6.45
$6.91
1週間の範囲:
$6.45
$7.37
52週間の値動き範囲:
$2.41
$10.37
Solid Biosciences Inc Stock (SLDB) Company Profile
名前
Solid Biosciences Inc
セクター
電話
617-337-4680
住所
500 RUTHERFORD AVENUE, CHARLESTOWN, MA
SLDB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SLDB
Solid Biosciences Inc
|
6.83 | 530.21M | 14.79M | -102.44M | -91.73M | -3.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Solid Biosciences Inc Stock (SLDB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-26 | 開始されました | Citigroup | Buy |
| 2025-01-08 | 開始されました | Truist | Buy |
| 2024-12-13 | 開始されました | Wedbush | Outperform |
| 2024-12-10 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-07-15 | アップグレード | JP Morgan | Neutral → Overweight |
| 2024-06-24 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-05-31 | 再開されました | Piper Sandler | Overweight |
| 2024-03-28 | 開始されました | William Blair | Outperform |
| 2024-03-15 | 開始されました | Citigroup | Buy |
| 2024-03-14 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-12-08 | 開始されました | H.C. Wainwright | Buy |
| 2021-07-12 | 開始されました | Piper Sandler | Neutral |
| 2021-05-27 | 開始されました | Jefferies | Buy |
| 2021-03-16 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-09 | 開始されました | Barclays | Overweight |
| 2021-01-08 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2020-07-28 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-05-07 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-10-11 | 開始されました | Evercore ISI | Outperform |
| 2019-08-29 | ダウングレード | Citigroup | Neutral → Sell |
| 2019-08-19 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-08-16 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2019-05-14 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2019-05-14 | ダウングレード | Goldman | Neutral → Sell |
| 2019-02-08 | アップグレード | Citigroup | Sell → Neutral |
| 2019-02-08 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2018-11-06 | 開始されました | Citigroup | Sell |
| 2018-09-06 | 開始されました | Credit Suisse | Neutral |
すべてを表示
Solid Biosciences Inc (SLDB) 最新ニュース
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Solid Biosciences Strengthens Team with 55,450 RSU Grants for Key Genetic Medicine Experts - Stock Titan
Is Solid Biosciences Inc. stock overvalued or undervaluedMarket Forecast Target Finder For Every Investor - jammulinksnews.com
What are the latest earnings results for Solid Biosciences Inc.Wealth Building Target Finder To Watch Now - jammulinksnews.com
Institutional Tools Highlight Unusual Flow in Solid Biosciences Inc.Optimized Watchlist With Daily Adjustments Launched - metal.it
What institutions are buying Solid Biosciences Inc. stock nowEarnings Play Trade Plan With Alerts Shared - metal.it
Technical Charts Suggest Momentum Shift in Solid Biosciences Inc.Oversold Recovery Opportunity Stocks Attract Buyers - metal.it
Solid Biosciences Inc. Approaches Support With Recovery in SightEntry Alert Based on Volume Spikes Detected - metal.it
Solid Biosciences’ SWOT analysis: gene therapy stock poised for growth amid challenges - Investing.com
What catalysts could drive Solid Biosciences Inc. stock higher in 2025Entry Signal Tracker For Consistent Profits - jammulinksnews.com
What makes Solid Biosciences Inc. stock price move sharplySmart Portfolio Recommendation For Beginners - jammulinksnews.com
What is the dividend policy of Solid Biosciences Inc. stockAchieve rapid portfolio growth with smart picks - jammulinksnews.com
Momentum Traders Eye Solid Biosciences Inc. for Quick BounceROI Boosting Trade Opportunity Calendar Published - metal.it
Should I hold or sell Solid Biosciences Inc. stock in 2025Access powerful market insights for free - jammulinksnews.com
Why Solid Biosciences Inc. stock attracts strong analyst attention2x Return Forecast - metal.it
How volatile is Solid Biosciences Inc. stock compared to the marketMarket-leading profit generation - jammulinksnews.com
Will Solid Biosciences Inc. stock benefit from interest rate changesFree Predictions - metal.it
J.P. Morgan Keeps Their Buy Rating on Solid Biosciences (SLDB) - The Globe and Mail
What drives Solid Biosciences Inc. stock priceTriple-digit wealth increases - Autocar Professional
J.P. Morgan Maintains Solid Biosciences(SLDB.US) With Buy Rating, Announces Target Price $15 - 富途牛牛
Is Solid Biosciences Inc. a good long term investmentUnstoppable profit momentum - PrintWeekIndia
Solid Biosciences Inc. Stock Analysis and ForecastExplosive capital gains - Autocar Professional
What analysts say about Solid Biosciences Inc. stockFree Popular Stock Recommendations - PrintWeekIndia
Solid Biosciences Receives FDA Fast Track Designation for - GlobeNewswire
Solid Biosciences and the Breakthrough Potential of SGT-501 for CPVT: A Rare Disease Play with Explosive Upside - AInvest
Solid Bio gets FDA fast track status for heart disease drug - Seeking Alpha
Solid Bio Green on Fast Track Nod - Baystreet.ca
Solid Biosciences receives FDA Fast Track designation for CPVT therapy By Investing.com - Investing.com Canada
Solid Biosciences receives FDA Fast Track designation for CPVT therapy - Investing.com Australia
Breakthrough CPVT Gene Therapy Receives Triple FDA Designations, Phase 1b Trial Set for Q4 2025 - Stock Titan
Solid Biosciences Inc (SLDB) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
0.15%
大文字化:
|
ボリューム (24 時間):